The effects of inducers of the endoplasmic reticulum, peroxisomes and mitochondria on the amounts and synthesis of ubiquinone in rat liver subcellular membranes.
Rats were treated with inducers of peroxisomes, mitochondria and the endoplasmic reticulum, as well as receiving diets and drug known to influence the mevalonate pathway. Treatment with clofibrate and 2-diethylhexylphthalate (DEHP) increased microsomal and mitochondrial ubiquinone contents, but a decrease was observed in lysosomes. In vivo labeling of this lipid with [3H]mevalonate was also elevated. The amount of cholesterol did not change upon exposure to these inducers of peroxisomes and mitochondria, but its rate of labeling was decreased. The concentration of dolichol increased only after treatment with DEHP and only in lysosomes. The inducers of the endoplasmic reticulum phenobarbital, 3-methylcholanthrene and N-nitrosodiethylamine enhanced the rate of ubiquinone synthesis and exposure to the latter two substances also elevated the amount of this lipid in microsomes. A cholesterol-rich diet increased the labeling of ubiquinone and decreased cholesterol labeling, while cholestyramine treatment had opposite effects on lipid labeling in both microsomes and mitochondria. The results demonstrate that the ubiquinone contents of the various membranes of hepatocytes change in a characteristic manner under the influence of inducers and dietary factors. Clearly, the level of ubiquinone and its biosynthesis are regulated separately from those of the other products of the mevalonate pathway, cholesterol and dolichol.
Kalén
A
A
Department of Cellular and Neuropathology, Huddinge Hospital, Sweden.
Appelkvist
E L
EL
Dallner
G
G
D000818:Animals; D002791:Cholesterol, Dietary / Q000494:pharmacology; D002792:Cholestyramine Resin / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D002994:Clofibrate / Q000494:pharmacology; D004051:Diethylhexyl Phthalate / Q000494:pharmacology; D004052:Diethylnitrosamine / Q000494:pharmacology; D004286:Dolichols / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism*; D007425:Intracellular Membranes / Q000187:drug effects / Q000378:metabolism*; D008099:Liver / Q000648:ultrastructure*; D008748:Methylcholanthrene / Q000494:pharmacology; D008798:Mevalonic Acid / Q000378:metabolism; D008830:Microbodies / Q000187:drug effects / Q000378:metabolism*; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014451:Ubiquinone / Q000378:metabolism*
D002791:Cholesterol, Dietary; D004286:Dolichols; D002792:Cholestyramine Resin; D014451:Ubiquinone; D004052:Diethylnitrosamine; D008748:Methylcholanthrene; D004051:Diethylhexyl Phthalate; D002994:Clofibrate; D008798:Mevalonic Acid; D010634:Phenobarbital